MBL2 and COVID-19: These results show that MBL2 polymorphisms, responsible for promoting a reduction in MBL levels and, therefore, in its function, contribute to the severity of COVID-19 and, low levels of MBL can help to intensify the inflammatory process, characteristic of severe disease.